urethral cancer
Showing 1 - 25 of 37
Urologic Cancer, Urologic Tumors, Bladder Cancer Trial in Boston (Electromagnetic Guided Laparoscopy, Ultrasound)
Not yet recruiting
- Urologic Cancer
- +7 more
- Electromagnetic Guided Laparoscopy
- Ultrasound
-
Boston, MassachusettsBrigham and Women's Hospital
Jun 8, 2023
Prostate Cancer, Renal Cancer, Urethral Cancer Trial in San Francisco (Copper-64 labeled Granzyme B (64Cu-GRIP B), Positron
Not yet recruiting
- Prostate Cancer
- +2 more
- Copper-64 labeled Granzyme B (64Cu-GRIP B)
- Positron Emission Tomography (PET)
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jun 7, 2023
Primary and Metastatic Tumors in Renal Cell Carcinoma and
Recruiting
- Renal Cell Carcinoma
- +4 more
- Immune checkpoint inhibitor targeting PD1
-
Philadelphia, PennsylvaniaFox Chase Cancer Center - Philadelphia
Jan 27, 2023
Solid Tumor, Urethral Cancer Trial in Houston (Bortezomib, Gemcitabine, Doxorubicin)
Active, not recruiting
- Solid Tumor
- Urethral Cancer
- Bortezomib
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 22, 2022
Melanoma, Breast Cancer, Uterine Cancer Trial in London (MRx0518 Capsules, MRx0518/ Capsules)
Active, not recruiting
- Melanoma
- +9 more
- MRx0518 Capsules
- MRx0518/placebo Capsules
-
London, United KingdomImperial College Healthcare NHS Trust
Aug 10, 2022
Pancreatic Cancer, Thyroid Cancer, Lung Cancer Trial in United States
Recruiting
- Pancreatic Cancer
- +49 more
-
Colorado Springs, Colorado
- +80 more
Feb 22, 2022
Urothelial Carcinoma, Bladder Cancer, Urethral Cancer Trial in United States (Biospecimen Collection)
Active, not recruiting
- Urothelial Carcinoma
- +3 more
- Biospecimen Collection
-
Los Angeles, California
- +7 more
Feb 14, 2022
Bladder Cancer, Urethral Cancer, Urachal Cancer Trial in Houston (5-Fluorouracil (5-FU), Leucovorin, Cisplatin)
Active, not recruiting
- Bladder Cancer
- +2 more
- 5-Fluorouracil (5-FU)
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
May 18, 2021
Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Ureter Cancer Trial in United Kingdom (carboplatin,
Completed
- Bladder Cancer
- +3 more
- carboplatin
- +3 more
-
Glasgow, Scotland, United Kingdom
- +20 more
May 14, 2019
Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in United States (gemcitabine
Completed
- Bladder Cancer
- +2 more
- gemcitabine hydrochloride
- paclitaxel
-
Cedar Rapids, Iowa
- +15 more
Dec 30, 2018
Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in United Kingdom (cisplatin,
Completed
- Bladder Cancer
- +2 more
- cisplatin
- +2 more
-
Bristol, Avon, United Kingdom
- +15 more
Oct 25, 2018
Kidney Cancer or Cancer of Urothelium and in Healthy
Completed
- Bladder Cancer
- +3 more
- immunologic technique
- +2 more
-
Winston-Salem, North CarolinaWake Forest University Comprehensive Cancer Center
Jul 3, 2018
Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in Leeds (cisplatin, gemcitabine
Completed
- Bladder Cancer
- +2 more
- cisplatin
- +3 more
-
Leeds, England, United KingdomLeeds Cancer Centre at St. James's University Hospital
Feb 2, 2018
Bladder Cancer, Ureter Cancer, Urethral Cancer Trial in Korea, Republic of (Treatment duration of cisplatin based chemo)
Unknown status
- Bladder Cancer
- +3 more
- Treatment duration of cisplatin based chemotherapy
-
Yangsan, Gyeongsangnam-do, Korea, Republic of
- +18 more
Sep 23, 2017
Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in United States (gemcitabine
Terminated
- Bladder Cancer
- +2 more
- gemcitabine hydrochloride
- paclitaxel
-
Mobile, Alabama
- +91 more
Jul 8, 2016
Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in New York (sunitinib malate)
Completed
- Bladder Cancer
- +2 more
- sunitinib malate
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Dec 17, 2015
Bladder Cancer, Urethral Cancer Trial in Houston (Recombinant Interferon Alfa)
Completed
- Bladder Cancer
- Urethral Cancer
- Recombinant Interferon Alfa
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
May 12, 2015
Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in Worldwide (fluorouracil)
Completed
- Bladder Cancer
- +2 more
-
Porto Alegre, Rio Grande do Sul, Brazil
- +61 more
Dec 3, 2013
Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in Milan (pazopanib HCl,
Completed
- Bladder Cancer
- +2 more
- pazopanib hydrochloride
- fludeoxyglucose F 18
-
Milan, ItalyFondazione Istituto Nazionale dei Tumori
Aug 9, 2013
Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in Barcelona, Madrid (drug,
Unknown status
- Bladder Cancer
- +2 more
- sunitinib malate
- +4 more
-
Barcelona, Spain
- +3 more
Aug 6, 2013
Bladder Cancer, Urethral Cancer Trial in New York (cisplatin, ifosfamide, paclitaxel)
Completed
- Bladder Cancer
- Urethral Cancer
- cisplatin
- +2 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jul 2, 2013